Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.

Kaiser, H B; Banov, C H; Berkowitz, R R; Bernstein, D I; Bronsky, E A; Georgitis, J W; Mendelson, L M; Rooklin, A R; Sholler, L J; Stricker, W W; Harrison, J E; Danzig, M R; Lorber, R R

Kaiser, H B; Banov, C H; Berkowitz, R R; Bernstein, D I; Bronsky, E A; Georgitis, J W; Mendelson, L M; Rooklin, A R; Sholler, L J; Stricker, W W; Harrison, J E; Danzig, M R; Lorber, R R.

Affiliation

Kaiser HB; Allergy & Asthma Specialists, PA, Minneapolis, MN 55402, USA.

Am J Ther ; 5(4): 245-51, 1998 Jul.

Article in En | MEDLINE | ID: mdl-10099066

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vasoconstrictor Agents / Rhinitis, Allergic, Seasonal / Loratadine / Anti-Allergic Agents / Ephedrine Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Am J Ther Journal subject: TERAPEUTICA Year: 1998 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links